Past Pharmaceutical Issues

Issue Summaries for the 112th Congress

(View issue summaries for the current Congress.)

Animal Drug User Fee Act Re-Authorization (ADUFA)
The Animal Drug User Fee Act (ADUFA), amends the Federal Food, Drug, and Cosmetic Act (FFDCA) and authorizes FDA to collect fees for certain animal drug applications. The AVMA supports user fees for new animal drug applications only if such fees are directed toward enhanced review and approval of animal drug products.

Primary Contact: Dr. Ashley Shelton Morgan  

This legislation would amend the Federal Food, Drug, and Cosmetic Act to purportedly preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. The AVMA opposes this legislation because it would eliminate "non-therapeutic" uses of antimicrobials which would disallow disease prevention and potentially control uses. The AVMA believes this could result in increased animal disease and death – an unfortunate and unintended consequence – without assurance of improving human health.  
Status: H.R.965 was introduced on March 9, 2011, by Rep. Louise Slaughter (D-NY-28). It was referred to both the U.S. House Committee on Energy and Commerce and the Rules Committee.
AVMA Position: Active Pursuit of Defeat
This legislation would impose new stipulations on veterinary prescriptions. The bill requires a veterinarian to 1) write a prescription whether or not he/she will dispense the product; 2) provide a written disclosure that clients may fill prescriptions at the veterinary clinic or at an off-site pharmacy; and 3) verify a prescription electronically or by other means consistent with applicable State law. 
Status: H.R.1406 was introduced on April 6, 2011 by Rep. Jim Matheson (D-UT-2). It was referred to the U.S. House Committee on Energy and Commerce's Subcommittee on Health.
AVMA Position: Active Pursuit of Defeat
Provides incentives for the development of qualified infectious disease products.
Status: H.R. 2182 was introduced on 6/15/11 and referred to House Committee on Energy and Commerce Subcommittee on Health. S. 1734 was introduced on 10/19/11 and referred to the Senate Committee on Health, Education, Labor and Pensions.
AVMA Position: Support 
Provides for increased Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths. Veterinarians seeking licensure by DEA would be impacted specifically by the "Section 4 Practitioner Education" provision. To be registered to prescribe or otherwise dispense methadone or other opioids, a practitioner would have to comply with the 16-hour training requirement at least once during each 3-year period.
Status: H.R. 1925 was introduced on 5/13/11 and referred to House Committee on Energy and Commerce Subcommittee on Health and House Judiciary Subcommittee on Crime, Terrorism and Homeland Security. S. 507 was introduced on 3/8/11 and referred to the Senate Committee on Health, Education, Labor and Pensions.
AVMA Position: Nonsupport
Primary Contact: Dr. Ashley Shelton Morgan